Heart Disease Clinical Trials in Salt Lake City

Showing 181-200 of 301 trials

A Study of VentriGel in Post-MI Patients

NCT02305602

This Phase I, open label, study will investigate the effects of VentriGel injection in patients who have experienced a first, large ST elevation myocardial infarction (STEMI) treated by PCI within the past 3 years and have evidence of left ventricular remodeling.

Myocardial InfarctionHeart FailureLeft Ventricular Remodeling

Ventrix, Inc.15 participantsStarted Sep 2015

Gilbert, Arizona, United States • Los Angeles, California, United States • Gainesville, Florida, United States +3 more locations

TERMINATEDPhase 3< 1 mile

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

NCT01975389

This study evaluates the PCSK9 inhibitor, Bococizumab (PF-04950615;RN316), compared to placebo, in reducing the occurrrence of major cardiovascular events, including cardiovascular death, myocardial infarction, stroke, and unstable angina requiring urgent revascularization in high risk subjects who are receiving background lipid lowering therapy and have cholesterol laboratory values of LDL-C \>/= 100 mg/dL (2.6 mmol/L) or non-HDL-C \>/=130 mg/dL (3.4 mmol/L).

Cardiovascular Disease

Pfizer10,564 participantsStarted Oct 2013

Athens, Alabama, United States • Athens, Alabama, United States • Birmingham, Alabama, United States +1592 more locations

A Study of VentriGel in Post-MI Patients

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Heart Disease Trials in Other Cities

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure

A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant

Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)

A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease

Evaluation of Cardiac Compass With OptiVol in the Early Detection of Decompensation Events for Heart Failure

VITROS Immunodiagnostic Products NT-proBNP II

Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation

DF4 Connector System Post-Approval Study

Evaluation of the Safety and Effectiveness of the DuraHeart™ LVAS

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)

Mitroflow DL Post Approval Study- North America

Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)

A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function

HW006 LATERAL Thoracotomy

Patient and Provider Assessment of Lipid Management Registry

Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis

Other Conditions in Salt Lake City